Nasdaq stocks posting largest percentage increases
AP - Fri Feb 13, 12:23PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
CYTK: 7.78 (+1.29), ADHD: 6.92 (+0.73), RCKY: 18.43 (+4.33), LPCN: 5.91 (+0.40), COLM: 51.50 (+7.91)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Feb 13, 11:45AM CST
CYTK: 7.78 (+1.29), MNOV: 3.62 (-0.56), MX: 7.52 (-7.50), SIEB: 1.71 (-0.24), QKLS: 2.10 (-0.24), YUMA: 1.88 (+0.67), CYBR: 52.52 (+6.83), KN: 18.59 (-3.05), COLM: 51.50 (+7.91), BIOC: 1.41 (+0.22), NBG: 1.61 (+0.18), CECO: 5.34 (-0.92), GENE: 8.04 (+1.90), SGNL: 3.91 (+2.15), IMI: 1.70 (-0.20), RCKY: 18.43 (+4.33), WAC: 20.29 (+2.57), FNJN: 2.77 (-0.36), ZNGA: 2.24 (-0.42), PRAN: 1.09 (-0.55)
Why Shares of Cytokinetics Incorporated Skyrocketed
George Budwell, The Motley Fool - Motley Fool - Fri Feb 13, 11:44AM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What : Shares of the clinical-stage biopharma Cytokinetics ...
CYTK: 7.78 (+1.29), AMGN: 153.48 (+0.30)
Cytokinetics updates guidance after Q4 results
Seeking Alpha - at Seeking Alpha - Fri Feb 13, 8:40AM CST
CYTK: 7.78 (+1.29)
Cytokinetics up premarket on earnings beat
Seeking Alpha - at Seeking Alpha - Fri Feb 13, 8:26AM CST
CYTK: 7.78 (+1.29)
Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Fri Feb 13, 8:15AM CST
CYTK: 7.78 (+1.29), HK: 2.18 (-0.02), CYBR: 52.52 (+6.83), FXEN: 1.99 (+0.10), NBG: 1.61 (+0.18), MBT: 10.36 (+0.62), SDRL: 12.32 (-0.70), MTSN: 4.04 (+0.19), BLDP: 2.66 (-0.26), GDP: 3.58 (+0.29), REXX: 5.08 (+0.13), DNR: 8.66 (+0.39), ZNGA: 2.24 (-0.42), KING: 16.70 (+1.96), SD: 2.09 (+0.14), MX: 7.52 (-7.50), KN: 18.59 (-3.05), GENE: 8.04 (+1.90), VDSI: 27.86 (+2.69), IDRA: 4.10 (-0.14), SFY: 2.91 (+0.26), ARIA: 7.35 (+0.45), FSL: 37.53 (+2.83), PRAN: 1.09 (-0.55), OAS: 16.84 (-0.03)
Upgrade Alert for Cytokinetics (CYTK)
Comtex SmarTrend(R) - Fri Feb 13, 6:50AM CST
Cytokinetics (NASDAQ:CYTK) was upgraded from Neutral to Overweight at Piper Jaffray today. The stock closed yesterday at $6.49 on volume of 211,000 shares, below average daily volume of 638,000. There is potential upside of 108.0% for shares of Cytokinetics based on a current price of $6.49 and an average consensus analyst price target of $13.50. The stock should find initial support at its 50-day moving average (MA) of $6.36 and further support at its 200-day MA of $4.77.
CYTK: 7.78 (+1.29)
Cytokinetics' (CYTK) CEO Robert Blum on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 12, 10:26PM CST
CYTK: 7.78 (+1.29)
Cytokinetics posts 4Q profit
Automated Insights - Thu Feb 12, 5:39PM CST
SOUTH SAN FRANCISCO, Calif. (AP) _ Cytokinetics Inc. (CYTK) on Thursday reported fourth-quarter earnings of $8.4 million.
CYTK: 7.78 (+1.29)
Cytokinetics beats by $0.40, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 3:46PM CST
CYTK: 7.78 (+1.29)
Cytokinetics, Incorporated (CYTK) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Feb 12, 3:25PM CST
CYTK: 7.78 (+1.29)
Cytokinetics, Incorporated Reports Fourth Quarter 2014 Financial Results
Thomson Reuters ONE - Thu Feb 12, 3:00PM CST
Ongoing Regulatory Interactions in US and Europe Inform Progression of Tirasemtiv to Phase III
CYTK: 7.78 (+1.29)
Cytokinetics Up 51.7% Since SmarTrend Uptrend Call (CYTK)
Comtex SmarTrend(R) - Wed Feb 11, 4:44PM CST
SmarTrend identified an Uptrend for Cytokinetics (NASDAQ:CYTK) on November 5th, 2014 at $4.23. In approximately 3 months, Cytokinetics has returned 51.72% as of today's recent price of $6.41.
CYTK: 7.78 (+1.29)
Uptrend Call Working As Cytokinetics Stock Rises 51.0% (CYTK)
Comtex SmarTrend(R) - Wed Feb 04, 10:59AM CST
SmarTrend identified an Uptrend for Cytokinetics (NASDAQ:CYTK) on November 5th, 2014 at $4.23. In approximately 3 months, Cytokinetics has returned 51.01% as of today's recent price of $6.38.
CYTK: 7.78 (+1.29)
Cytokinetics to Announce Fourth Quarter Results on February 12, 2015
PRWeb - Thu Jan 29, 4:00PM CST
Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that it is scheduled to report fourth quarter results on Thursday, February 12, 2015 at 4:00 PM Eastern Time. Following the announcement, Cytokinetics' senior management will host a conference call at 4:30 PM Eastern Time to discuss operational and financial results and the company's outlook for the future.
CYTK: 7.78 (+1.29)
Cytokinetics Up 80.4% Since SmarTrend Uptrend Call (CYTK)
Comtex SmarTrend(R) - Wed Jan 28, 9:31AM CST
SmarTrend identified an Uptrend for Cytokinetics (NASDAQ:CYTK) on November 5th, 2014 at $4.23. In approximately 3 months, Cytokinetics has returned 80.36% as of today's recent price of $7.62.
CYTK: 7.78 (+1.29)
Shares of CYTK Up 83.0% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Jan 21, 9:04AM CST
SmarTrend identified an Uptrend for Cytokinetics (NASDAQ:CYTK) on November 5th, 2014 at $4.23. In approximately 3 months, Cytokinetics has returned 82.96% as of today's recent price of $7.73.
CYTK: 7.78 (+1.29)
Will Cytokinetics (CYTK) Continue to Surge Higher? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jan 20, 5:57AM CST
Will Cytokinetics (CYTK) Continue to Surge Higher?
CYTK: 7.78 (+1.29)
Uptrend Call Working As Cytokinetics Stock Rises 76.6% (CYTK)
Comtex SmarTrend(R) - Tue Jan 13, 4:42PM CST
SmarTrend identified an Uptrend for Cytokinetics (NASDAQ:CYTK) on November 5th, 2014 at $4.23. In approximately 2 months, Cytokinetics has returned 76.57% as of today's recent price of $7.46.
CYTK: 7.78 (+1.29)